Publications

Publications

China proposes new rules to address perceived anti-competitive practices in the pharmaceutical industry

On 14 August 2017, the National Development and Reform Commission ("NDRC") released a draft of the Guidelines on Pricing Conduct by Business Operators for Drugs in Shortage and Active...

Publications

MOFCOM rules that foreign to foreign deal jumped the gun in breach of antitrust rules

In a decision adopted on 16 December 2016 and made public on 4 January 2017, the Chinese Ministry of Commerce ("MOFCOM") fined Japanese company Canon for failure to file its...

Publications

TMT China Brief - Summer/Fall 2016

This edition features a total of 19 articles which capture the significant TMT developments in Greater China since our last TMT China Brief. The sheer number of articles is testimony to the ...

Published Works

All eyes on antitrust enforcement in China's pharmaceutical industry

A wide range of recent antitrust enforcement actions in the pharmaceutical sector have taken place in China over the past months.

Publications

Two steps forward one step back

The proposed amendments to China’s Anti-Unfair Competition Law.

Published Works

Chinese Competition Law - The Year 2015 in Review

For Chinese competition law, the year 2015 was a "mixed bag" of developments characterized by both change and continuity.

Published Works

China Anti-Monopoly Law Update: 2015 Review and 2016 Forecast

In retrospect, 2015 will possibly be viewed as a year of transition for Chinese antitrust law. On the one hand, there appears to have been a change in pace in the enforcement of the...

Hogan Lovells Publications

Chinese Pharma Company Fined for Refusal to Supply Downstream Competitors

On 22 December 2015, the State Administration for Industry and Commerce (SAIC) published the decision of its local branch in Chongqing (Chongqing AIC) against pharma company Chongqing...

;
Loading data